FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfilePacific Edge Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
PEB.AX
Pacific Edge Limited Stock AnalysisComprehensive stock analysis for Pacific Edge Limited (PEB.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisPEB.AX
PEB.AX
Pacific Edge Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
PEB.AX
  1. Home
  2. Stocks
  3. Pacific Edge Limited

Pacific Edge Limited

🇦🇺PEB.AX•ASX

Pacific Edge Limited

🇦🇺PEB.AX•ASX

Your view on PEB.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Pacific Edge Limited

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Peter Meintjes
Headquarters
Centre for Innovation, Dunedin, OTA, NZ
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Peter Meintjes
Headquarters
Centre for Innovation, Dunedin, OTA, NZ
Description

Pacific Edge Limited, a cancer diagnostics firm headquartered in Dunedin, New Zealand, and established in 2001, is dedicated to the research, development, and commercialization of advanced diagnostic and prognostic tools.

These innovations are designed for the early identification and ongoing management of various cancers, with the company's activities spanning New Zealand, the United States, Australia, and Singapore. Its operations are divided into distinct Commercial and Research segments.

Central to its product offerings is Cxbladder, a suite of genomic urine tests specifically tailored for the detection and clinical management of bladder cancer.

The company is actively expanding this portfolio with several new developments: Cxbladder Resolve, which aims to identify patients likely to have aggressive or more advanced bladder cancer; Cxbladder Triage, designed to flag individuals with haematuria who have a low probability of bladder cancer; Cxbladder Detect, enabling the non-invasive discovery of bladder and other urinary tract cancers; and Cxbladder Monitor, a tool for urologists to track bladder cancer recurrence in patients.

In addition to its focus on bladder cancer, Pacific Edge is also progressing with Cxcolorectal, a prognostic gene signature intended for patients diagnosed with stage II or stage III colorectal cancers.

Furthermore, the company's development pipeline includes products targeting diagnostics for bladder, gastric, colorectal, and endometrial cancers, as well as melanoma.

FRC Research

Past Reports

Historical coverage archive.

FRC Research
1 report
Mar 16, 2011

Updated Resource Estimate $ Added 1.2 Mt Inferred Resources Grading 2.12% Cu Eq - FINAL REPORT

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Pacific Edge Limited. Starting points for Pacific Edge Limited: EPS -AUD 0.03, beta 0.84 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Pacific Edge Limited. Pacific Edge Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Pacific Edge Limited. Trailing twelve-month EPS for Pacific Edge Limited stands at -AUD 0.03. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Pacific Edge Limited. Pacific Edge Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold PEB.AX12 companies
More Medical - Diagnostics & Research companies
TickerTypeCompanySectorExchangeMkt cap
SPDESpeedus Corp.HealthcareOTC$416
SZLSFStageZero Life Sciences Ltd.HealthcareOTC$61,766
TDSGFTelo Genomics Corp.HealthcareOTC$3.8M
TELO.VTelo Genomics Corp.HealthcareTSXV$4.0M
THOXFBioPorto A/SHealthcareOTC$73.8M
TMOThermo Fisher Scientific Inc.HealthcareNYSE$248.1B
TMO.NEThermo Fisher Scientific Inc.HealthcareNEO—
TOMDFTodos Medical Ltd.HealthcareOTC$14,081
TTOOT2 Biosystems, Inc.HealthcareOTC$11,218
TWSTTwist Bioscience CorporationHealthcareNASDAQ$7.0B
VCYTVeracyte, Inc.HealthcareNASDAQ$2.0B
VIMGFVimian Group AB (publ)HealthcareOTC$1.5B
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Pacific Edge Limited. Coverage tracks Pacific Edge Limited within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Pacific Edge Limited.

PEB.AX AnalysisFair
Past
5
Growth
1
Health
4
Profit
1
Value
1